Small Tax-Withholding Stock Sale by BeOne Medicines Chief John Oyler
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
BeOne Medicines (ONC) filed a routine Form 4 showing CEO/Director John Oyler’s mandatory tax-withholding sale of 3,174 American Depositary Shares (≈41,262 ordinary shares) on 06/23/2025 at an average price of about $262, totaling roughly $0.83 million.
Post-sale, Oyler still controls ≈54.2 million ordinary shares through direct and indirect holdings, so his ownership percentage is effectively unchanged. No other transactions or material changes were disclosed.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 3,174 shares ($830,360)
Net Sell
8 txns
Insider
OYLER JOHN
Role
Chief Executive Officer
Sold
3,174 shs ($830K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | American Depositary Shares | 3,074 | $261.5712 | $804K |
| Sale | American Depositary Shares | 100 | $262.90 | $26K |
| holding | Ordinary Shares | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
Holdings After Transaction:
American Depositary Shares — 100 shares (Direct);
Ordinary Shares — 8,173,759 shares (Direct);
Ordinary Shares — 481,533 shares (Indirect, See Footnote)
Footnotes (1)
- These securities are held by the P&O Trust, the beneficiaries of which include the Reporting Person's child and others, for which the Reporting Person disclaims beneficial ownership. These securities are held in a grantor retained annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership. These securities are held by Oyler Investment LLC, of which 99% of the the limited liability company interest owned by a grantor retain annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership. These securities are held for the benefit of the Reporting Person in a Roth IRA PENSCO trust account. These securities are held by The John Oyler Legacy Trust for the benefit of the Reporting Person's minor child, for which the Reporting Person disclaims beneficial ownership. Each American Depositary Share represents 13 Ordinary Shares The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 22, 2022, subject to continued service. Unvested securities are subject to accelerated vesting upon change of control or certain termination events.
FAQ
How many BeOne Medicines (ONC) ADS did CEO John Oyler sell on June 23 2025?
He sold 3,174 ADS, each representing 13 ordinary shares.
What was the average price received for the ADS sold by Oyler?
The ADS were sold at prices of $261.5712 and $262.90, averaging about $262 per ADS.
What is the total dollar value of Oyler’s sale reported in the Form 4?
The transaction generated approximately $0.83 million in gross proceeds.